Betaloan Suik Injection, Suspension
Product Images NDC 80425-0347

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Betaloan Suik (NDC 80425-0347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 1 (Betaloan Suik Kit 80425 0347 01)

Label for Betaloan SUIK 6MG/ML KIT, an injection suspension containing betamethasone sodium phosphate and betamethasone acetate. The label shows storage instructions at 20°-25°C, a barcode, lot number, expiration date 7/28/2023, and is marked Rx only. It is packed by Advanced Rx Pharmacy of Tennessee, LLC in Nashville, TN.*

FDA Label Image

Betamethasone Sodium Phosphate (Bet0b 0002 01)

Chemical structure of Betamethasone Sodium Phosphate, showing its molecular framework including rings, hydroxyl, ketone, phosphate, and fluorine components as part of the active ingredient in Betaloan SUIK injection suspension.*

FDA Label Image

Betamethasone Acetate (Bet0b 0002 02)

Chemical structure diagram of Betamethasone, the active ingredient in Betaloan SUIK injection suspension, showing its corticosteroid molecular framework with functional groups and stereochemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.